FEB 25, 2021 8:00 AM PST

Asthma Inhalers Slash Risk of COVID Hospitalization by 90 Percent

WRITTEN BY: Tara Fernandez

For mild cases of COVID, doctors recommend the usual regimen for getting through a cold or flu: Staying hydrated and resting at home. For those experiencing severe COVID symptoms, receiving a hospital-administered dose of an approved therapy such as monoclonal antibodies is the best option.

But what if an over-the-counter drug could help reduce the need for hospitalization altogether? An international team of researchers has conducted a trial demonstrating that inhalers used to treat asthma can help patients avoid urgent care.

As part of the STOIC (STerOids In COVID-19) study, researchers tested the potential of a corticosteroid called budesonide as a means of providing relief for COVID patients. Nearly 150 patients enrolled in the trial, half of whom received the asthma inhaler twice a day within seven days of the onset of symptoms. The other half received current standards of treatment.

Those that inhaled budesonide experienced accelerated recovery times. More importantly, the treatment reduced the relative risk of ending up in the emergency room by 90 percent over the course of the month-long study.

The data from the trial have been published on the medRxiv pre-print server.

Asthma is a chronic inflammatory disease of the airways that causes shortness of breath, chest tightness, coughing, and wheezing. Many asthma patients have their inhalers close at hand for quick relief when symptoms begin to creep up. The steroids in the inhalers work by quickly relaxing the airway muscles so that they can breathe easily again.

The potential of deploying inhaled corticosteroids as a COVID countermeasure could have a tremendous impact on communities everywhere, particularly those with limited access to healthcare facilities.

“The possibility of reducing the long-term effects from persistent COVID-19 symptoms is also exciting. This cheap and widely available intervention can be rolled out very quickly across the world while we wait for vaccines to get to everyone,” said Sanjay Ramakrishnan, one of the authors of the study.

 

 

Sources: QUT, medRxiv


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
MAR 14, 2021
Immunology
How Are Allergies Developed?
MAR 14, 2021
How Are Allergies Developed?
You might have experienced it yourself or met someone that can not eat a certain food or can not take a specific medicat ...
JAN 28, 2021
Immunology
Killers With a Hit on the Spike
JAN 28, 2021
Killers With a Hit on the Spike
Natural killer cells, or NK cells, are specialized immune cells of the innate immune system. Their job revolves around e ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
MAR 31, 2021
Microbiology
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
MAR 31, 2021
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
Scientists took an exploratory journey to a place in the central Pacific Ocean in Kirbati called the Phoenix Islands Pro ...
APR 11, 2021
Genetics & Genomics
Trial Shows Personalized Cancer Vaccines are Safe
APR 11, 2021
Trial Shows Personalized Cancer Vaccines are Safe
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin ...
Loading Comments...